Rubraca 200 mg
Rubraca 200 mg is a medicine authorised by Swissmedic under authorisation number 67402. The authorisation holder is mmpharm GmbH. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 26 November 2020 and the authorisation is valid without a time limit. ATC code L01XK03 places the medicine in the group Antineoplastic agents.
| Authorisation number | 67402 |
|---|---|
| Name | Rubraca 200 mg |
| Full name | Rubraca 200 mg, Filmtabletten |
| Authorisation holder | mmpharm GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01XK03 |
| First authorisation | 26 November 2020 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Rubraca 200 mg, Filmtabletten | A | 26 November 2020 |
| 2 | Rubraca 250 mg, Filmtabletten | A | 26 November 2020 |
| 3 | Rubraca 300 mg, Filmtabletten | A | 26 November 2020 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 60 | Tablette(n) | L01XK03 | 07.16.1. | A |
| 4 | 120 | Tablette(n) | L01XK03 | 07.16.1. | A |
| 2 | 60 | Tablette(n) | L01XK03 | 07.16.1. | A |
| 5 | 120 | Tablette(n) | L01XK03 | 07.16.1. | A |
| 3 | 60 | Tablette(n) | L01XK03 | 07.16.1. | A |
| 6 | 120 | Tablette(n) | L01XK03 | 07.16.1. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Rubraca 200 mg authorised in Switzerland?
Yes. Rubraca 200 mg is authorised by Swissmedic under authorisation number 67402, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Rubraca 200 mg have?
Rubraca 200 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Rubraca 200 mg?
The authorisation holder is mmpharm GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.